Literature DB >> 29704874

The convergence theory for vitiligo: A reappraisal.

Roopal V Kundu1, Julia M Mhlaba1, Stephanie M Rangel1, I Caroline Le Poole1,2.   

Abstract

Vitiligo is characterized by progressive loss of skin pigmentation. The search for aetiologic factors has led to the biochemical, the neurologic and the autoimmune theory. The convergence theory was then proposed several years ago to incorporate existing theories of vitiligo development into a single overview of vitiligo aetiology. The viewpoint that vitiligo is not caused only by predisposing mutations, or only by melanocytes responding to chemical/radiation exposure, or only by hyperreactive T cells, but rather results from a combination of aetiologic factors that impact melanocyte viability, has certainly stood the test of time. New findings have since informed the description of progressive depigmentation. Understanding the relative importance of such aetiologic factors combined with a careful selection of the most targetable pathways will continue to drive the next phase in vitiligo research: the development of effective therapeutics. In that arena, it is likewise important to acknowledge that pathways affected in some patients may not be altered in others. Taken together, the convergence theory continues to provide a comprehensive viewpoint of vitiligo aetiology. The theory serves to intertwine aetiologic pathways and will help to define pathways amenable to disease intervention in individual patients.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autoimmune; depigmentation; melanocyte; vitiligo aetiology

Year:  2018        PMID: 29704874      PMCID: PMC6204319          DOI: 10.1111/exd.13677

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  141 in total

1.  Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines.

Authors:  Silvia Moretti; Adelina Spallanzani; Lauretta Amato; Giuseppe Hautmann; Isabella Gallerani; Paolo Fabbri
Journal:  Arch Dermatol       Date:  2002-02

2.  HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.

Authors:  K S Lang; C C Caroli; A Muhm; D Wernet; A Moris; B Schittek; E Knauss-Scherwitz; S Stevanovic; H G Rammensee; C Garbe
Journal:  J Invest Dermatol       Date:  2001-06       Impact factor: 8.551

3.  Herpesvirus connection in the expression of autoimmune vitiligo in Smyth line chickens.

Authors:  G F Erf; T K Bersi; X Wang; G P Sreekumar; J R Smyth
Journal:  Pigment Cell Res       Date:  2001-02

4.  A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses.

Authors:  S Wang; S Bartido; G Yang; J Qin; Y Moroi; K S Panageas; J J Lewis; A N Houghton
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  'VIT1', a novel gene associated with vitiligo.

Authors:  I C Le Poole; R Sarangarajan; Y Zhao; L S Stennett; T L Brown; P Sheth; T Miki; R E Boissy
Journal:  Pigment Cell Res       Date:  2001-12

6.  New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.

Authors:  Silvia Moretti; Adelina Spallanzani; Lauretta Amato; Giuseppe Hautmann; Isabella Gallerani; Massimo Fabiani; Paolo Fabbri
Journal:  Pigment Cell Res       Date:  2002-04

7.  Genetic association of the catalase gene (CAT) with vitiligo susceptibility.

Authors:  Courtney B Casp; Jin-Xiong She; Wayne T McCormack
Journal:  Pigment Cell Res       Date:  2002-02

8.  Differentiation of murine melanocyte precursors induced by 1,25-dihydroxyvitamin D3 is associated with the stimulation of endothelin B receptor expression.

Authors:  Hidenori Watabe; Yoshinao Soma; Yoko Kawa; Masaru Ito; Shiho Ooka; Kayoko Ohsumi; Takako Baba; Tamihiro Kawakami; Eri Hosaka; Satoko Kimura; Masako Mizoguchi
Journal:  J Invest Dermatol       Date:  2002-09       Impact factor: 8.551

Review 9.  Multiple pathways to tumor immunity and concomitant autoimmunity.

Authors:  Mary Jo Turk; Jedd D Wolchok; José A Guevara-Patino; Stacie M Goldberg; Alan N Houghton
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

Review 10.  Vitiligo: a manifestation of apoptosis?

Authors:  Carol L Huang; James J Nordlund; Raymond Boissy
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

View more
  7 in total

1.  Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.

Authors:  M El-Domyati; W H El-Din; A F Rezk; I Chervoneva; J B Lee; M Farber; J Uitto; O Igoucheva; Vitali Alexeev
Journal:  Arch Dermatol Res       Date:  2021-04-17       Impact factor: 3.017

Review 2.  Skin pigmentation and its control: From ultraviolet radiation to stem cells.

Authors:  Joseph Michael Yardman-Frank; David E Fisher
Journal:  Exp Dermatol       Date:  2020-12-24       Impact factor: 3.960

3.  Eruptive Halo Naevi: A Possible Indicator of Malignant Disease in a Case Series of Post-Adolescent Patients.

Authors:  Henrik F Lorentzen
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

4.  Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.

Authors:  Zhussipbek Mukhatayev; Emilia R Dellacecca; Cormac Cosgrove; Rohan Shivde; Dinesh Jaishankar; Katherine Pontarolo-Maag; Jonathan M Eby; Steven W Henning; Yekaterina O Ostapchuk; Kettil Cedercreutz; Alpamys Issanov; Shikhar Mehrotra; Andreas Overbeck; Richard P Junghans; Joseph R Leventhal; I Caroline Le Poole
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

5.  Multimodal analyses of vitiligo skin identify tissue characteristics of stable disease.

Authors:  Jessica Shiu; Lihua Zhang; Griffin Lentsch; Jessica L Flesher; Suoqin Jin; Christopher Polleys; Seong Jin Jo; Craig Mizzoni; Pezhman Mobasher; Jasmine Kwan; Francisca Rius-Diaz; Bruce J Tromberg; Irene Georgakoudi; Qing Nie; Mihaela Balu; Anand K Ganesan
Journal:  JCI Insight       Date:  2022-07-08

Review 6.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

Review 7.  A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.

Authors:  Shahnawaz D Jadeja; Jay M Mayatra; Jayvadan Vaishnav; Nirali Shukla; Rasheedunnisa Begum
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.